Gerald W. McLaughlin's Net Worth

$1.49 Million

Estimate Recalculated Feb 28, 2025 06:55PM EST

Who is Gerald W. McLaughlin?

Gerald W. McLaughlin has an estimated net worth of $1.49 Million. This is based on reported shares across multiple companies, which include NUPATHE INC., Neos Therapeutics, Inc., AYTU BIOPHARMA, INC, Nemus Bioscience, Inc., and Allarity Therapeutics, Inc..

SEC CIK

Gerald W. McLaughlin's CIK is 0001495412

Past Insider Trading and Trends

2015 was Gerald W. McLaughlin's most active year for acquiring shares with 4 total transactions. Gerald W. McLaughlin's most active month to acquire stocks was the month of February. 2021 was Gerald W. McLaughlin's most active year for disposing of shares, totalling 7 transactions. Gerald W. McLaughlin's most active month to dispose stocks was the month of February. 2018 saw Gerald W. McLaughlin paying a total of $51,239.01 for 624,500 shares, this is the most they've acquired in one year. In 2014 Gerald W. McLaughlin cashed out on 242,400 shares for a total of $1,494,581.28, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NUPATHE INC. No price found

SVP, Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-156.65K
$6.80
-$1,065,226.80
0
Feb 21
Form 4
+394.93%
125K
—
—
156.65K
Jan 17
Form 4
∞
31.65K
—
—
31.65K
Jan 7
Form 4
—
0
—
—
0
Mar 8
Form 3
—
0
—
—
0
No matching records found

Neos Therapeutics, Inc. No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-270.17K
—
—
0
Mar 19
Form 4
-14.10%
-44.33K
$0.84
-$37,413.68
270.17K
Mar 2
Form 4
—
0
—
—
0
Mar 13
Form 4
+1,183.67%
290K
—
—
314.5K
Mar 2
Form 4/A
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Mar 1
Form 4
+230.95%
17.1K
$2.11
$36,119.12
24.5K
Dec 6
Form 4
∞
7.4K
$2.04
$15,119.89
7.4K
Dec 4
Form 4
—
0
—
—
0
Jun 27
Form 3
—
0
—
—
0
No matching records found

AYTU BIOPHARMA, INC (AYTU) Snapshot price: $2.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+26.10%
6.5K
—
—
31.4K
Apr 8
Form 3
—
0
—
—
0
No matching records found

Nemus Bioscience, Inc. (SKYE) Snapshot price: $5.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+96.00%
30K
—
—
61.25K
Oct 20
Form 4
∞
31.25K
—
—
31.25K
Aug 20
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Dec 4
Form 3
—
0
—
—
0
No matching records found

Allarity Therapeutics, Inc. (ALLR) Snapshot price: $0.165

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found